Overall, CRP and IL-6 levels and consequently the risk of a stroke incrementally increases from the NPD to PD to T2D group, as a result of worsening metabolic and inflammatory profiles, with prediabetes representing an intermediate stage of the inflammatory response. This evidence concerns the gene CRP and prediabetes syndrome.